Renalytix Plc (AIM: RENX)
London
· Delayed Price · Currency is GBP · Price in GBX7.53
-0.23 (-2.90%)
Nov 19, 2024, 10:44 AM GMT+1
Renalytix Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2018 |
| Revenue | 2.35 | 2.29 | 3.4 | 2.97 | 1.49 | - | Upgrade
|
| Revenue Growth (YoY) | -18.70% | -32.74% | 14.58% | 99.20% | - | - | Upgrade
|
| Cost of Revenue | 2.05 | 2.13 | 2.68 | 2.1 | 0.86 | - | Upgrade
|
| Gross Profit | 0.3 | 0.16 | 0.72 | 0.87 | 0.63 | - | Upgrade
|
| Selling, General & Admin | 17.12 | 19.91 | 28.66 | 39.52 | 23.48 | 5.75 | Upgrade
|
| Research & Development | 7.27 | 9.14 | 14.3 | 14.65 | 10.04 | 4.57 | Upgrade
|
| Operating Expenses | 24.39 | 29.04 | 42.96 | 54.17 | 33.52 | 10.32 | Upgrade
|
| Operating Income | -24.09 | -28.89 | -42.24 | -53.3 | -32.89 | -10.32 | Upgrade
|
| Interest & Investment Income | 0.2 | 0.2 | 0.1 | 0.01 | 0.2 | 0.1 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.01 | 0.01 | -2.11 | -0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.09 | 0.16 | 0.36 | 9.69 | -8.77 | 0.45 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | 0.15 | 0.36 | 0.12 | 1.41 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | -23.93 | -28.37 | -41.44 | -43.46 | -42.17 | -9.94 | Upgrade
|
| Merger & Restructuring Charges | -0.72 | -0.72 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.06 | -0.61 | -1.08 | -5.9 | 6.48 | 0.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.05 | - | Upgrade
|
| Other Unusual Items | -3.31 | -3.75 | -3.09 | 4.11 | 0.3 | - | Upgrade
|
| Pretax Income | -28.02 | -33.45 | -45.61 | -45.25 | -35.34 | -9.84 | Upgrade
|
| Income Tax Expense | 0.01 | 0 | 0 | 0.03 | - | - | Upgrade
|
| Earnings From Continuing Operations | -28.03 | -33.46 | -45.61 | -45.28 | -35.34 | -9.84 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.61 | - | Upgrade
|
| Net Income | -28.03 | -33.46 | -45.61 | -45.28 | -34.73 | -9.84 | Upgrade
|
| Net Income to Common | -28.03 | -33.46 | -45.61 | -45.28 | -34.73 | -9.84 | Upgrade
|
| Shares Outstanding (Basic) | 111 | 108 | 82 | 73 | 71 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 111 | 108 | 82 | 74 | 71 | 59 | Upgrade
|
| Shares Change (YoY) | 27.19% | 31.59% | 11.34% | 3.29% | 21.00% | 38.81% | Upgrade
|
| EPS (Basic) | -0.25 | -0.31 | -0.55 | -0.62 | -0.49 | -0.17 | Upgrade
|
| EPS (Diluted) | -0.25 | -0.31 | -0.55 | -0.67 | -0.49 | -0.17 | Upgrade
|
| Free Cash Flow | -24.45 | -30.12 | -34.09 | -46.48 | -29.17 | -10.33 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.28 | -0.41 | -0.63 | -0.41 | -0.17 | Upgrade
|
| Gross Margin | 12.71% | 6.82% | 21.16% | 29.43% | 42.45% | - | Upgrade
|
| Operating Margin | -1024.15% | -1261.90% | -1241.26% | -1794.55% | -2205.63% | - | Upgrade
|
| Profit Margin | -1191.75% | -1461.60% | -1340.20% | -1524.44% | -2328.97% | - | Upgrade
|
| Free Cash Flow Margin | -1039.41% | -1315.64% | -1001.62% | -1565.02% | -1956.54% | - | Upgrade
|
| EBITDA | -23.89 | -28.62 | -41.93 | -53.01 | -32.69 | -10.25 | Upgrade
|
| D&A For EBITDA | 0.2 | 0.26 | 0.31 | 0.29 | 0.2 | 0.07 | Upgrade
|
| EBIT | -24.09 | -28.89 | -42.24 | -53.3 | -32.89 | -10.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.